Resumen acción UNICHEMLAB
Unichem Laboratories Limited, empresa farmacéutica, fabrica y vende productos farmacéuticos en todo el mundo.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Unichem Laboratories Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹549.70 |
| 52 Week High | ₹572.00 |
| 52 Week Low | ₹366.40 |
| Beta | 0.14 |
| 1 Month Change | 4.26% |
| 3 Month Change | 19.92% |
| 1 Year Change | 42.35% |
| 3 Year Change | 66.63% |
| 5 Year Change | 189.62% |
| Change since IPO | 850.71% |
Noticias y actualizaciones recientes
Recent updates
Optimistic Investors Push Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares Up 26% But Growth Is Lacking
Feb 06
Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Due To Pay A Dividend Of ₹4.00
Jul 30There's Reason For Concern Over Unichem Laboratories Limited's (NSE:UNICHEMLAB) Massive 28% Price Jump
Jul 23Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 15Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 01Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Investors Shouldn't Be Too Comfortable With Unichem Laboratories' (NSE:UNICHEMLAB) Robust Earnings
Jun 05Should Unichem Laboratories Limited (NSE:UNICHEMLAB) Be Part Of Your Income Portfolio?
Mar 02Unichem Laboratories Limited's (NSE:UNICHEMLAB) Stock's Been Going Strong: Could Weak Financials Mean The Market Will Correct Its Share Price?
Feb 09Should You Take Comfort From Insider Transactions At Unichem Laboratories Limited (NSE:UNICHEMLAB)?
Jan 19Do Institutions Own Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares?
Dec 29Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Key Things To Understand About Unichem Laboratories' (NSE:UNICHEMLAB) CEO Pay Cheque
Nov 23
Did Unichem Laboratories' (NSE:UNICHEMLAB) Share Price Deserve to Gain 41%?
Nov 02Should You Buy Unichem Laboratories Limited (NSE:UNICHEMLAB) For Its 1.5% Dividend?
Oct 13How Much Are Unichem Laboratories Limited (NSE:UNICHEMLAB) Insiders Spending On Buying Shares?
Sep 16Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26Is Unichem Laboratories Limited's (NSE:UNICHEMLAB) Shareholder Ownership Skewed Towards Insiders?
Aug 05Would Shareholders Who Purchased Unichem Laboratories'(NSE:UNICHEMLAB) Stock Three Years Be Happy With The Share price Today?
Jul 14Rentabilidad de los accionistas
| UNICHEMLAB | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 0.6% | -3.0% | -1.7% |
| 1Y | 42.4% | 56.8% | 45.0% |
Rentabilidad vs. Industria: UNICHEMLAB obtuvo unos resultados inferiores a los del sector Indian Pharmaceuticals , que el año pasado arrojó un rendimiento del 65.6%.
Rentabilidad vs. Mercado: UNICHEMLAB obtuvo unos resultados inferiores a los del mercado Indian, que fue del 46.9% el año pasado.
Volatilidad de los precios
| UNICHEMLAB volatility | |
|---|---|
| UNICHEMLAB Average Weekly Movement | 8.1% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: UNICHEMLAB no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de UNICHEMLAB (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1944 | 2,894 | Pabitrakumar Bhattacharyya | www.unichemlabs.com |
Unichem Laboratories Limited, empresa farmacéutica, fabrica y vende productos farmacéuticos en todo el mundo. Ofrece productos de formulación que abordan diversas áreas terapéuticas, como gastroenterología, cardiología, diabetología, psiquiatría, neurología, antibacterianos, antiinfecciosos y tratamiento del dolor; e ingredientes farmacéuticos activos, así como servicios de fabricación por contrato. La empresa también fabrica medicamentos alopáticos, fármacos a granel y productos químicos.
Resumen de fundamentos de Unichem Laboratories Limited
| Estadísticas fundamentales de UNICHEMLAB | |
|---|---|
| Capitalización bursátil | ₹38.70b |
| Beneficios(TTM) | ₹145.69m |
| Ingresos (TTM) | ₹16.75b |
265.6x
Ratio precio-beneficio (PE)2.3x
Ratio precio-ventas (PS)¿Está UNICHEMLAB sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de UNICHEMLAB | |
|---|---|
| Ingresos | ₹16.75b |
| Coste de los ingresos | ₹7.27b |
| Beneficio bruto | ₹9.49b |
| Otros gastos | ₹9.34b |
| Beneficios | ₹145.69m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 2.07 |
| Margen bruto | 56.63% |
| Margen de beneficio neto | 0.87% |
| Ratio deuda/patrimonio | 12.1% |
¿Cómo se ha desempeñado UNICHEMLAB a largo plazo?
Ver rendimiento histórico y comparativa